PBCAR19B

· Precision BioSciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBCAR19B, covering 2024-07-26 to 2024-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies [Phase 1]